BIIB SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Shareholders of a Class Action Involving Biogen Inc. & a Lead...
November 21 2016 - 10:28AM
Business Wire
The Law Offices of Vincent Wong announce that a class action
lawsuit has been commenced in the USDC for the District of
Massachusetts on behalf of investors who purchased Biogen Inc.
(NASDAQ:BIIB) securities between July 23, 2014 and July 23,
2015.
Click here to learn about the case:
http://www.wongesq.com/pslra/biogen-inc. There is no cost or
obligation to you.
According to the complaint, defendants employed devices, schemes
and artifices to defraud, while in possession of material adverse
non-public information, in an effort to assure investors of
Biogen’s value and performance and continued substantial growth. In
particular, the complaint alleges that the Company failed to
disclose material information about the Company’s business,
particularly in regards to their Tecfidera drug treatment.
In 2014, the MS Institute at Shepherd Center in Georgia, a
prescriber of Tecfidera, began conducting blood tests of MS
patients taking the drug. By August of that year, the Center began
notifying Biogen that Tecfidera was causing low lymphocyte counts
among approximately 30% of the Center’s MS patients taking the
drug; eventually the Center stopped prescribing Tecfidera and
transferred many of its patients to other therapies. Biogen,
however, continued to tout the safety and growing sales of
Tecfidera throughout the second and third quarter of 2014.
If you suffered a loss in Biogen you have until December 23,
2016 to request that the Court appoint you as lead plaintiff. Your
ability to share in any recovery doesn’t require that you serve as
a lead plaintiff. To obtain additional information, contact Vincent
Wong, Esq. either via email vw@wongesq.com, by telephone at
212.425.1140, or visit
http://www.wongesq.com/pslra/biogen-inc.
Vincent Wong, Esq. is an experienced attorney that has
represented investors in securities litigations involving financial
fraud and violations of shareholder rights. Attorney advertising.
Prior results do not guarantee similar outcomes.
CONTACT:Vincent Wong, Esq.39 East BroadwaySuite 304New York, NY
10002Tel. 212.425.1140Fax. 866.699.3880E-Mail: vw@wongesq.com
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161121005756/en/
Law Offices of Vincent WongVincent Wong,
Esq.212.425.1140vw@wongesq.com
Biogen (NASDAQ:BIIB)
Historical Stock Chart
From Aug 2024 to Sep 2024
Biogen (NASDAQ:BIIB)
Historical Stock Chart
From Sep 2023 to Sep 2024